Adi Zuloff-Shani
Chief Executive Officer at CLEARMIND MEDICINE INC.
Net worth: 1 929 $ as of 2024-03-30
Profile
Adi Zuloff-Shani is currently the Chief Executive Officer at Clearmind Medicine, Inc., Chairman at Orsus Therapeutics Plc, and Chief Technology Officer at SciSparc Ltd.
Previously, Adi held the position of Vice President-Development at Macrocure Ltd.
from 2012 to 2016.
Adi's education includes undergraduate and doctorate degrees from Bar-Ilan University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CLEARMIND MEDICINE INC.
0.05% | 2023-10-30 | 1,667 ( 0.05% ) | 1 917 $ | 2024-03-30 |
SCISPARC LTD.
0.00% | 2023-04-23 | 7 ( 0.00% ) | 12 $ | 2024-03-30 |
Adi Zuloff-Shani active positions
Companies | Position | Start |
---|---|---|
SCISPARC LTD. | Chief Tech/Sci/R&D Officer | 2016-02-07 |
CLEARMIND MEDICINE INC. | Chief Executive Officer | 2021-07-13 |
Orsus Therapeutics Plc | Chairman | 2021-10-31 |
Former positions of Adi Zuloff-Shani
Companies | Position | End |
---|---|---|
MACROCURE LTD | Corporate Officer/Principal | 2015-12-31 |
Training of Adi Zuloff-Shani
Bar-Ilan University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SCISPARC LTD. | Health Technology |
CLEARMIND MEDICINE INC. | Health Technology |
Private companies | 2 |
---|---|
Macrocure Ltd.
Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
Orsus Therapeutics Plc |
- Stock Market
- Insiders
- Adi Zuloff-Shani